RPS17: A Potential Drug Target and Diagnostic Tool for Cancer

Target Name: RPS17

NCBI ID: G6218

RPS17

RPS17: A Potential Drug Target and Diagnostic Tool for Cancer

Ribosomal protein S17 (RPS17) is a protein that is expressed in most eukaryotic cells and plays a critical role in protein synthesis. It is a key component of the ribosome, which is the protein machine that synthesizes proteins in the cell. RPS17 functions as a structural protein that helps keep the ribosome together and forms the active site for protein synthesis.

Recent studies have suggested that RPS17 may have potential as a drug target or biomarker. One potential mechanism by which RPS17 could be targeted is through its role in cell signaling. RPS17 has been shown to play a role in regulating cell signaling pathways, including the regulation of cell growth, apoptosis, and autophagy.

Additionally, RPS17 has also been shown to be involved in the regulation of protein synthesis, which is a critical process for the development and maintenance of cellular organelles and tissues. Mutations in the RPS17 gene have been shown to lead to protein synthesis defects, which could potentially be the cause of a variety of cellular disorders.

Another potential mechanism by which RPS17 could be used as a drug target is its role in the development of cancer. RPS17 has been shown to be involved in the regulation of cell cycle progression, which is a critical process for the development of cancer. Mutations in the RPS17 gene have been shown to lead to changes in cell cycle behavior, which could potentially make them more susceptible to cancer-promoting therapies.

In addition to its potential as a drug target or biomarker, RPS17 has also been shown to have potential as a diagnostic tool. Analysis of RPS17 levels in cancer tissues has been shown to be a sensitive and reliable method for the diagnosis of cancer, particularly in cases where other diagnostic tests may be difficult to interpret.

Overall, RPS17 is a protein that has significant potential as a drug target or biomarker, particularly in the context of cancer. Further research is needed to fully understand its role in cell signaling and protein synthesis, as well as its potential as a diagnostic tool.

Protein Name: Ribosomal Protein S17

Functions: Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797)

The "RPS17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets